State regulation of private health insurance: Prescription drug benefits, experimental treatments, and consumer protection

Jane Nelson Bolin, Robert J. Buchanan, Scott R. Smith

Research output: Contribution to journalArticle

Abstract

This study analyzes the results of 2 surveys sent to state insurance commissioners that focused on policies regulating conventional health insurance and managed care organizations (MCOs) during 2000. Surveys were returned by 49 states and the District of Columbia. Several states have implemented regulations mandating prescription drug coverage. In addition, some states now require health insurers and MCOs to cover the medical care associated with experimental medications and treatments. Some states have also created laws allowing beneficiaries to sue their health insurer or MCO for damages caused by denial of care. These state policies provide a rich source of data for federal policy makers to analyze as they consider new patient protection legislation and amendments to the Employee Retirement Income Security Act.

Original languageEnglish (US)
Pages (from-to)977-985
Number of pages9
JournalAmerican Journal of Managed Care
Volume8
Issue number11
StatePublished - Nov 2002

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'State regulation of private health insurance: Prescription drug benefits, experimental treatments, and consumer protection'. Together they form a unique fingerprint.

Cite this